Your browser doesn't support javascript.
When Should Perioperative Glucocorticoid Replacement Be Administered?
Evidence-Based Practice of Anesthesiology (Fourth Edition) ; : 217-225, 2023.
Article in English | ScienceDirect | ID: covidwho-1881583
ABSTRACT
Perioperative glucocorticoid replacement has been used in a variety of clinical conditions. Glucocorticoids have several benefits, such as antiinflammatory and immunosuppressant effects. Routine perioperative use, however, has been limited by side effects, lack of efficacy, and conflicting trial results. Nevertheless, glucocorticoid replacement is indicated in certain situations, including refractory septic shock, early moderate-to-severe acute respiratory distress syndrome, severe COVID-19, and relative adrenal insufficiency in patients undergoing surgical procedures. Further investigations are required to determine optimal glucocorticoid dosing and timing, identify patient subsets who benefit from replacement therapy, and reconcile conflicting results from clinical studies.
Keywords

Full text: Available Collection: Databases of international organizations Database: ScienceDirect Language: English Journal: Evidence-Based Practice of Anesthesiology (Fourth Edition) Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: ScienceDirect Language: English Journal: Evidence-Based Practice of Anesthesiology (Fourth Edition) Year: 2023 Document Type: Article